Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2005, Vol. 10 ›› Issue (12): 1335-1339.

Previous Articles     Next Articles

Repression activity of recombinant oncostatin M on proliferation and mi-gration of tumorcells

OUYANG Li-ming, LIU Jian-wen1   

  1. College of Bioengineering;
    1 College of Pharmaceuticals,East China University of Science and Technology,Shanghai 200237,China
  • Received:2005-09-29 Revised:2005-10-31 Online:2005-12-26 Published:2020-11-11

Abstract: AIM: To investigate the inhibition ability of recombinant Oncostatin M(OSM) to proliferation and migration of tumorcells.METHODS: Expressed and purified human OSM from recombinant E.Coli,and as-sayed its pharmacology activity by a series of experiments in vitro to metastatic human lung cancercell line 95-D including MTT assay,clone formationassay in soft agar,cell attachment assay,cell migration assay and invasion cuPassay.RESULTS AND CONCLUSION: rhOSM displayed strong activity of inhibiting the proliferation and migration of 95-D.Prokaryoticly expressed hOSM has po-tential clinical value to lung cancer.

Key words: oncostatin M, metastatic human lung cancercell line 95-D, metastasis

CLC Number: